A machine learning study of the effect of thrombolysis on outcome at discharge in the UK stroke registry: how does benefit compare with clinical trials?
Open Access
- 6 July 2026
- journal article
- research article
- Published by Oxford University Press (OUP) in European Stroke Journal
- Vol. 11 (7)
Abstract
Thrombolysis has been shown to reduce disability after acute ischaemic stroke in randomised trials. Our study sought to compare the benefit from thrombolysis observed in a comprehensive national stroke registry with that expected from the clinical trials. Data from a total of 168,347 ischaemic stroke patients who attended one of 118 emergency stroke hospitals in England and Wales from 2016 to 2021 were extracted from the Sentinel Stroke National Audit Programme. We constructed a machine learning model, designed to isolate the effect of thrombolysis, using explainable machine learning (XGBoost with SHapley Additive exPlanations [SHAP]). Thrombolysis was found to be associated with a statistically significant improvement in the odds of achieving a better outcome (modified Rankin scale [mRS] threshold). Regression analysis predicted a maximum 2.5-fold improvement in odds of achieving mRS 0-1, with a decline to no treatment effect at 5 h 28 min post-onset. Our results confirm a beneficial effect of thrombolysis in a large prospective national stroke registry, and align closely with meta-analyses of clinical trials of thrombolysis both in terms of magnitude of effect and decline over time. This work also demonstrates the potential to apply explainable machine learning to observational data to assist in understanding how clinical trials are implemented in real-world settings. Thrombolysis, in practice, has the same observed benefit as in the clinical trials.Keywords
Funding Information
- National Institute for Health and Care Research Applied Research Collaboration South West
- National Institute for Health Research Health and Social Care Delivery Research (HSDR) Programme (NIHR134326)
- National Institute for Health Research Health and Social Care Delivery Research (HSDR) Programme (NIHR168927)
This publication has 12 references indexed in Scilit:
- Intravenous Alteplase Versus Best Medical Therapy for Patients With Minor Stroke: A Systematic Review and Meta-AnalysisStroke, 2024
- Thrombolysis Is Not Indicated for Minor Strokes If They Are Truly NondisablingStroke, 2024
- Use of Clinical Pathway Simulation and Machine Learning to Identify Key Levers for Maximizing the Benefit of Intravenous Thrombolysis in Acute StrokeStroke, 2022
- Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Neurology, 2021
- Predicting 90-day modified Rankin Scale score with discharge information in acute ischaemic stroke patients following treatmentBMJ Neurology Open, 2021
- Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experimentInternational Journal of Stroke, 2017
- XGBoost2016
- Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsThe Lancet, 2014
- Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational studyThe Lancet, 2008
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007